Renaissance Technologies’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$924K Sell
99,372
-16,628
-14% -$155K ﹤0.01% 2558
2025
Q1
$781K Sell
116,000
-200,000
-63% -$1.35M ﹤0.01% 2550
2024
Q4
$3.36M Buy
316,000
+304,700
+2,696% +$3.24M 0.01% 1702
2024
Q3
$165K Sell
11,300
-82,000
-88% -$1.2M ﹤0.01% 3160
2024
Q2
$1.13M Buy
93,300
+47,782
+105% +$578K ﹤0.01% 2256
2024
Q1
$1.12M Sell
45,518
-75,982
-63% -$1.87M ﹤0.01% 2415
2023
Q4
$1.3M Buy
121,500
+89,100
+275% +$953K ﹤0.01% 2228
2023
Q3
$271K Sell
32,400
-12,100
-27% -$101K ﹤0.01% 2982
2023
Q2
$352K Buy
44,500
+15,600
+54% +$123K ﹤0.01% 3059
2023
Q1
$144K Buy
28,900
+7,800
+37% +$38.9K ﹤0.01% 3383
2022
Q4
$47K Sell
21,100
-400
-2% -$891 ﹤0.01% 3808
2022
Q3
$95K Hold
21,500
﹤0.01% 3613
2022
Q2
$69K Buy
21,500
+7,500
+54% +$24.1K ﹤0.01% 3936
2022
Q1
$80K Buy
+14,000
New +$80K ﹤0.01% 3829
2021
Q3
Sell
-20,400
Closed -$353K 3637
2021
Q2
$353K Buy
+20,400
New +$353K ﹤0.01% 3089